Madrigal Pharmaceuticals Inc
NASDAQ:MDGL

Watchlist Manager
Madrigal Pharmaceuticals Inc Logo
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
Watchlist
Price: 309.83 USD -1.69% Market Closed
Market Cap: 6.7B USD
Have any thoughts about
Madrigal Pharmaceuticals Inc?
Write Note

Net Margin
Madrigal Pharmaceuticals Inc

-675.2%
Current
-320%
Average
-7.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-675.2%
=
Net Income
-518.7m
/
Revenue
76.8m

Net Margin Across Competitors

Country US
Market Cap 6.4B USD
Net Margin
-675%
Country FR
Market Cap 6T USD
Net Margin
-21 040%
Country US
Market Cap 300.2B USD
Net Margin
9%
Country US
Market Cap 158.7B USD
Net Margin
13%
Country US
Market Cap 126.8B USD
Net Margin
-5%
Country US
Market Cap 115B USD
Net Margin
0%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country AU
Market Cap 137.3B AUD
Net Margin
18%
Country US
Market Cap 88.3B USD
Net Margin
34%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country NL
Market Cap 34.1B EUR
Net Margin
-14%

Profitability Report

View the profitability report to see the full profitability analysis for Madrigal Pharmaceuticals Inc.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-675.2%
=
Net Income
-518.7m
/
Revenue
76.8m
What is the Net Margin of Madrigal Pharmaceuticals Inc?

Based on Madrigal Pharmaceuticals Inc's most recent financial statements, the company has Net Margin of -675.2%.